Skip to main content
TipRanks
Go Ultimate75% OFF

Moleculin Biotech (MBRX) Q4 2022 Earnings Report

2,022 Followers

MBRX Q4 2022 EPS Results

Actual EPS
-$1,725.00
Consensus EPS
-$2,275.00
Beat/Miss
Beat by +$550.00
One Year Ago EPS
-$1,350.00

MBRX Q4 2022 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2022
Date
03/23/2023
Time
Before Open
Conference Call
Thursday, March 23, 2023
MBRX Upcoming Earnings

Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

MBRX Q4 2022 Earnings Call
0:00 / 0:00

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

MBRX Earnings History

MBRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 19, 20272026 (Q4)―-2.61――
Aug 14, 20262026 (Q2)-31.07-28.00-24588.57% (+217.00)
May 15, 20262026 (Q1)-46.67-70.80-34579.48% (+274.20)
Mar 19, 20262025 (Q4)-122.2752.20125-58.24% (-72.80)
Nov 17, 20252025 (Q3)-6.58-17.02-71.2576.12% (+54.23)
Aug 13, 20252025 (Q2)-215.00-245.00-85071.18% (+605.00)
May 14, 20252025 (Q1)-277.50-345.00-101065.84% (+665.00)
Mar 24, 20252024 (Q4)-641.67125.00-2510104.98% (+2635.00)
Nov 11, 20242024 (Q3)-1220.00-1425.00-14250.00% (+0.00)
Aug 14, 20242024 (Q2)-1255.00-850.00-150043.33% (+650.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed